Literature DB >> 8834710

Effect of surgical treatment on hypertension in Cushing's syndrome.

F Fallo1, N Sonino, L Barzon, M Pistorello, U Pagotto, A Paoletta, M Boscaro.   

Abstract

The effect of a surgical cure of hypercortisolism on hypertension in 54 patients with Cushing's syndrome was assessed. The correlation between preoperative duration of hypertension and posttreatment blood pressure was significant (P < .01). Restoration of normal cortisol was associated with blood pressure normalization in 39 out of 54 cases. Duration of hypertension of patients with normalized blood pressure was significantly shorter than that of patients with persistent hypertension postoperatively (P < .0001). Duration of hypertension, ie, long-lasting exposure to increased cortisol, appears to be the determinant of persistent hypertension following successful surgery in Cushing's syndrome.

Entities:  

Mesh:

Year:  1996        PMID: 8834710     DOI: 10.1016/0895-7061(95)00299-5

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

1.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 2.  Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.

Authors:  N Sonino; G A Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Glucocorticoid excess and hypertension.

Authors:  Smita Baid; Lynnette K Nieman
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

Review 4.  Hypercortisolism in obesity-associated hypertension.

Authors:  Amy G Varughese; Oksana Nimkevych; Gabriel I Uwaifo
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

5.  Blood pressure in pediatric patients with Cushing syndrome.

Authors:  Maya B Lodish; Ninet Sinaii; Nicholas Patronas; Dalia L Batista; Meg Keil; Jonelle Samuel; Jason Moran; Somya Verma; Jadranka Popovic; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

6.  Treatment of Cushing disease: overview and recent findings.

Authors:  Tatiana Mancini; Teresa Porcelli; Andrea Giustina
Journal:  Ther Clin Risk Manag       Date:  2010-10-21       Impact factor: 2.423

7.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2015-07-29       Impact factor: 5.958

8.  Remission in Cushing's disease is predicted by cortisol burden and its withdrawal following pituitary surgery.

Authors:  A Dutta; N Gupta; R Walia; A Bhansali; P Dutta; S K Bhadada; R Pivonello; C K Ahuja; S Dhandapani; A Hajela; C Simeoli; N Sachdeva; U N Saikia
Journal:  J Endocrinol Invest       Date:  2021-01-16       Impact factor: 4.256

9.  The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome.

Authors:  Minghan Wang
Journal:  Nutr Metab (Lond)       Date:  2005-02-02       Impact factor: 4.169

Review 10.  Comorbidities in Cushing's disease.

Authors:  S T Sharma; L K Nieman; R A Feelders
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.